These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 28222123)

  • 1. Deriving effective vaccine allocation strategies for pandemic influenza: Comparison of an agent-based simulation and a compartmental model.
    Dalgıç ÖO; Özaltın OY; Ciccotelli WA; Erenay FS
    PLoS One; 2017; 12(2):e0172261. PubMed ID: 28222123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal allocation of pandemic influenza vaccine depends on age, risk and timing.
    Mylius SD; Hagenaars TJ; Lugnér AK; Wallinga J
    Vaccine; 2008 Jul; 26(29-30):3742-9. PubMed ID: 18524428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of inventory information in allocating a limited supply of influenza vaccine during a pandemic.
    Li Z; Swann JL; Keskinocak P
    PLoS One; 2018; 13(10):e0206293. PubMed ID: 30359445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination strategies for future influenza pandemics: a severity-based cost effectiveness analysis.
    Kelso JK; Halder N; Milne GJ
    BMC Infect Dis; 2013 Feb; 13():81. PubMed ID: 23398722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiological and economic impact of pandemic influenza in Chicago: Priorities for vaccine interventions.
    Dorratoltaj N; Marathe A; Lewis BL; Swarup S; Eubank SG; Abbas KM
    PLoS Comput Biol; 2017 Jun; 13(6):e1005521. PubMed ID: 28570660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A computer simulation of vaccine prioritization, allocation, and rationing during the 2009 H1N1 influenza pandemic.
    Lee BY; Brown ST; Korch GW; Cooley PC; Zimmerman RK; Wheaton WD; Zimmer SM; Grefenstette JJ; Bailey RR; Assi TM; Burke DS
    Vaccine; 2010 Jul; 28(31):4875-9. PubMed ID: 20483192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal pandemic influenza vaccine allocation strategies for the Canadian population.
    Tuite AR; Fisman DN; Kwong JC; Greer AL
    PLoS One; 2010 May; 5(5):e10520. PubMed ID: 20463898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient Vaccine Distribution Based on a Hybrid Compartmental Model.
    Yu Z; Liu J; Wang X; Zhu X; Wang D; Han G
    PLoS One; 2016; 11(5):e0155416. PubMed ID: 27233015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An analysis of national target groups for monovalent 2009 pandemic influenza vaccine and trivalent seasonal influenza vaccines in 2009-10 and 2010-11.
    Ng S; Wu P; Nishiura H; Ip DK; Lee ES; Cowling BJ
    BMC Infect Dis; 2011 Aug; 11():230. PubMed ID: 21871096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Equalizing access to pandemic influenza vaccines through optimal allocation to public health distribution points.
    Huang HC; Singh B; Morton DP; Johnson GP; Clements B; Meyers LA
    PLoS One; 2017; 12(8):e0182720. PubMed ID: 28854244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influenza H3N2 variant viruses with pandemic potential: preventing catastrophe in remote and isolated Canadian communities.
    Laskowski M; Duvvuri VR; Buckeridge DL; Wu G; Wu J; Moghadas SM
    Prev Med; 2013 Dec; 57(6):910-3. PubMed ID: 23628518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prioritization of delayed vaccination for pandemic influenza.
    Shim E
    Math Biosci Eng; 2011 Jan; 8(1):95-112. PubMed ID: 21361402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does cost-effectiveness of influenza vaccine choice vary across the U.S.? An agent-based modeling study.
    DePasse JV; Nowalk MP; Smith KJ; Raviotta JM; Shim E; Zimmerman RK; Brown ST
    Vaccine; 2017 Jul; 35(32):3974-3981. PubMed ID: 28606814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A model-based economic analysis of pre-pandemic influenza vaccination cost-effectiveness.
    Halder N; Kelso JK; Milne GJ
    BMC Infect Dis; 2014 May; 14():266. PubMed ID: 24884470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimizing influenza vaccine distribution.
    Medlock J; Galvani AP
    Science; 2009 Sep; 325(5948):1705-8. PubMed ID: 19696313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age groups and spread of influenza: implications for vaccination strategy.
    Hsieh YH
    BMC Infect Dis; 2010 Apr; 10():106. PubMed ID: 20429954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cost effectiveness of pandemic influenza interventions: a pandemic severity based analysis.
    Milne GJ; Halder N; Kelso JK
    PLoS One; 2013; 8(4):e61504. PubMed ID: 23585906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination deep into a pandemic wave potential mechanisms for a "third wave" and the impact of vaccination.
    Lee BY; Brown ST; Cooley P; Grefenstette JJ; Zimmerman RK; Zimmer SM; Potter MA; Rosenfeld R; Wheaton WD; Wiringa AE; Bacon KM; Burke DS
    Am J Prev Med; 2010 Nov; 39(5):e21-9. PubMed ID: 20965375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influenza vaccination coverage against seasonal and pandemic influenza and their determinants in France: a cross-sectional survey.
    Vaux S; Van Cauteren D; Guthmann JP; Le Strat Y; Vaillant V; de Valk H; Lévy-Bruhl D
    BMC Public Health; 2011 Jan; 11():30. PubMed ID: 21226919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009.
    Skowronski DM; Janjua NZ; De Serres G; Hottes TS; Dickinson JA; Crowcroft N; Kwindt TL; Tang P; Charest H; Fonseca K; Gubbay JB; Bastien N; Li Y; Petric M
    BMJ; 2011 Feb; 342():c7297. PubMed ID: 21292718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.